-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Survivorship in adult patients with lymphoma

Program: Spotlight Sessions
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Clinical Practice (Health Services and Quality), Adverse Events
Sunday, December 11, 2022: 4:30 PM-5:45 PM
Great Hall AD (Ernest N. Morial Convention Center)
Javid J. Moslehi, MD, University of California San Francisco
Moslehi: BMS: Consultancy, Honoraria; AstraZeneca: Consultancy, Honoraria; BeiGene: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Cytokinetics: Consultancy, Honoraria; Myovant: Consultancy, Honoraria; TranstheraBio: Consultancy, Honoraria.
Lymphoma patients are surviving their initial bout with cancer in increasing numbers. Long-term health has become an important consideration for patients. In this session, we will highlight some of the most recent developments in this area especially with new NCCN guidelines. Special focus will be on cardio-oncology, cardiovascular health for this patient population.  In addition, presenters will discuss surveillance for secondary malignancies and psychosocial outcomes in lymphoma survivors.

Javid J. Moslehi, MD

Section of Cardio-Oncology & Immunology, University of California San Francisco, San Francisco, CA

Carrie A. Thompson, MD

Division of Hematology, Mayo Clinic, Rochester, MN

See more of: Spotlight Sessions